1. ScholarBank@NUS

Andrew Michael Lindsay Lever

rp31200

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Andrew Michael Lindsay Lever
(not current staff)
Variants
Andrew M L Lever
 
Main Affiliation
 
Faculty
 
Email
mdcamll@nus.edu.sg
 

Publications

Refined By:
File Format:  Adobe PDF
Subject:  nonhuman

Results 1-20 of 26 (Search time: 0.018 seconds).

Issue DateTitleAuthor(s)
120082008 Nobel prize in Medicine for discoverers of HIVLever, A.M.L ; Berkhout, B
22006A method to estimate the efficiency of gene expression from an integrated retroviral vectorMok, H.P; Lever, A 
32018An RNA-binding compound that stabilizes the HIV-1 gRNA packaging signal structure and specifically blocks HIV-1 RNA encapsidationIngemarsdotter, C.K; Zeng, J; Long, Z; Lever, A.M.L ; Kenyon, J.C 
42018CD32-expressing CD4 T cells are phenotypically diverse and can contain proviral HIV DNAMartin, G.E; Pace, M; Thornhill, J.P; Phetsouphanh, C; Meyerowitz, J; Gossez, M; Brown, H; Olejniczak, N; Lwanga, J; Ramjee, G; Kaleebu, P; Porter, K; Willberg, C.B; Klenerman, P; Nwokolo, N; Fox, J; Fidler, S; Frater, J; Lever, A ; Wills, M; Weber, J; Dorrell, L; Malim, M; Gupta, R; Jolly, C; On Behalf of the CHERUB Investigato
52016Coordination of genomic RNA packaging with viral assembly in HIV-1Hellmund, C; Lever, A.M.L 
62007Dimerisation of HIV-2 genomic RNA is linked to efficient RNA packaging, normal particle maturation and viral infectivityL'Hernault, A; Greatorex, J.S; Crowther, R.A; Lever, A.M.L 
72015Evidence that the endosomal sorting complex required for transport-II (ESCRT-II) is required for efficient human immunodeficiency virus-1 (HIV-1) productionMeng, B; Ip, N.C.Y; Prestwood, L.J; Abbink, T.E.M; Lever, A.M.L 
82013Experimental Pathways towards Developing a Rotavirus Reverse Genetics System: Synthetic Full Length Rotavirus ssRNAs Are Neither Infectious nor Translated in Permissive CellsRichards J.E.; Desselberger U.; Lever A.M. 
92016HIV and Zika: When will we be able to end these epidemics?Wainberg, M.A; Lever, A.M.L 
102014How will the ebola crisis impact the HIV epidemic?Wainberg, M.A; Lever, A.M 
112015Identification of RNA helicases in human immunodeficiency virus 1 (HIV-1) replication – A targeted small interfering RNA library screen using pseudotyped and WT HIV-1Williams, C.A; Abbink, T.E.M; Jeang, K.-T; Lever, A.M.L 
122005Identification of unique reciprocal and non reciprocal cross packaging relationships between HIV-1, HIV-2 and SIV reveals an efficient SIV/HIV-2 lentiviral vector system with highly favourable features for in vivo testing and clinical usageStrappe, P.M; Hampton, D.W; Bown, D; Gonzalez, B.-C; Caldwell, M; Fawcett, J.W; Lever, A.M.L 
132013Immune adaptor ADAP in T cells regulates HIV-1 transcription and cell-cell viral spread via different co-receptorsWei, B; Han, L; Abbink, T.E.M; Groppelli, E; Lim, D; Thaker, Y.R; Gao, W; Zhai, R; Wang, J; Lever, A ; Jolly, C; Wang, H; Rudd, C.E
142013Inhibition of rotavirus replication by downregulation of fatty acid synthesisGaunt, E.R; Cheung, W; Richards, J.E; Lever, A ; Desselberger, U
152017Innovations in the quantitative virus outgrowth assay and its use in clinical trialsNorton, N.J; Fun, A; Bandara, M; Wills, M.R; Mok, H.P; Lever, A.M.L 
162013Lipidome analysis of rotavirus-infected cells confirms the close interaction of lipid droplets with viroplasmsGaunt, E.R; Zhang, Q; Cheung, W; Wakelam, M.J.O; Lever, A.M.L ; Desselberger, U
172013Monsef Benkirane awarded 2013 Ming K. Jeang Foundation Retrovirology Prize: Landmark HIV-1 research honouredBerkhout, B; Lever, A ; Wainberg, M; Fassati, A; Borrow, P; Fujii, M
182018No evidence of ongoing evolution in replication competent latent HIV-1 in a patient followed up for two yearsMok, H.P; Norton, N.J; Hirst, J.C; Fun, A; Bandara, M; Wills, M.R; Lever, A.M.L 
192007Rapamycin-induced inhibition of HTLV-I LTR activity is rescued by c-MybRose, N.J; Lever, A.M.L 
202009Rev: Beyond nuclear exportGroom, H.C.T; Anderson, E.C; Lever, A.M.L